Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-07
1997-01-14
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, A61K 3135
Patent
active
055940250
ABSTRACT:
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5286753 (1994-02-01), Schaus et al.
patent: 5306830 (1994-04-01), Andersson et al.
patent: 5426229 (1995-06-01), Schaus et al.
patent: 5466709 (1995-11-01), Schaus et al.
Bulbring, E., et al., Adv. Pharmac., 6A, 323-333 (1968).
Blundell, J. E., Neuropharmacology, 23, 1537-1551 (1984).
Gidda Jaswant S.
Schaus John M.
Demeter John C.
Eli Lilly and Company
Weddington Kevin E.
LandOfFree
Method of inhibiting gastric acid secretion with 5-substituted-3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting gastric acid secretion with 5-substituted-3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting gastric acid secretion with 5-substituted-3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388625